Home/Stock Analysis/ANRO

ANRO

Alto Neuroscience, Inc.

NYSE

Healthcare • Biotechnology

Updated 22 days ago

Coverage limited

Factor tilt: Balanced Profile

Portfolio context

We’ll show you if ANRO is in your portfolio and how much it contributes.

Market context

Loading market dates

No dividend ex-date available

No 8-K filings in the last 30 days.

Smart money context

Holder IQ: HIGH

as of 2025-Q1 (filed 2025-05-15)

214 top institutions tracked

as of 2025-Q1 (filed 2025-05-15)

Note: 13F filings are reported up to 45 days after quarter-end.

Insider context

Sentiment: unknown

No recent insider trades detected.

Red flags: 0

Track CEO, CFO, and director trades

Why it matters

Holder IQ: high. as of 2025-Q1 (filed 2025-05-15).

Why it matters

No red flags detected

Why it matters

Get the Full Analysis for ANRO

Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.